BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol 2022;15:18. [PMID: 35236381 DOI: 10.1186/s13045-022-01235-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Guo Y, Wang Q. USP21 accelerates the proliferation and glycolysis of esophageal cancer cells by regulating the STAT3/FOXO1 pathway. Tissue and Cell 2022;79:101916. [DOI: 10.1016/j.tice.2022.101916] [Reference Citation Analysis]
2 Mo H, Wang X, Ji G, Liang X, Yang Y, Sun W, Jia X, Xu L, Qiao Y, Zhou H, Zhao W, Fu S, Zhang X. The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma. BMC Genomics 2022;23:769. [DOI: 10.1186/s12864-022-09010-9] [Reference Citation Analysis]
3 Ma Y, He X, Di Y, Liu S, Zhan Q, Bai Z, Qiu T, Corpe C, Wang J. Identification of prognostic immune-related lncRNAs in pancreatic cancer. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1005695] [Reference Citation Analysis]
4 Wu W, Wang S, Zhang L, Mao B, Wang B, Wang X, Zhao D, Zhao P, Mou Y, Yan P. Mechanistic studies of MALAT1 in respiratory diseases. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.1031861] [Reference Citation Analysis]
5 Du T, Liu R, Zhang Q, Luo H, Liu Z, Sun S, Wang X. EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis. Biomolecules 2022;12:1617. [DOI: 10.3390/biom12111617] [Reference Citation Analysis]
6 Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Entezari M, Taheriazam A, Hushmandi K. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomedicine & Pharmacotherapy 2022;155:113774. [DOI: 10.1016/j.biopha.2022.113774] [Reference Citation Analysis]
7 Zandieh MA, Farahani MH, Rajabi R, avval ST, Karimi K, Rahmanian P, Razzazan M, Javanshir S, Mirzaei S, Paskeh MDA, Salimimoghadam S, Hushmandi K, Taheriazam A, Pandey V, Hashemi M. Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106582] [Reference Citation Analysis]
8 Huang Q, You Q, Zhu N, Wu Z, Xiang Z, Wu K, Ren J, Gui Y. Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis-related long non-coding RNA signature. J Clin Lab Anal 2022;:e24723. [PMID: 36189780 DOI: 10.1002/jcla.24723] [Reference Citation Analysis]
9 Hashemi M, Hasani S, Hajimazdarany S, Mirmazloomi SR, Makvandy S, Zabihi A, Goldoost Y, Gholinia N, Kakavand A, Tavakolpournegari A, Salimimoghadam S, Nabavi N, Zarrabi A, Taheriazam A, Entezari M, Hushmandi K. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.09.203] [Reference Citation Analysis]
10 Xu S, Luo W, Li M, Li Q, Hong W, Gao Y, Yang J, Song H, Chen L, Yang Y, Yang C. Circ_0001667 promotes adriamycin resistance and malignant progression via targeting the miR-193a-5p/Rap2A molecular axis in breast cancer. Clinical Breast Cancer 2022. [DOI: 10.1016/j.clbc.2022.09.008] [Reference Citation Analysis]
11 Zhang X, Luo M, Zhang J, Guo B, Singh S, Lin X, Xiong H, Ju S, Wang L, Zhou Y, Zhou J. The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. Front Genet 2022;13:1005522. [DOI: 10.3389/fgene.2022.1005522] [Reference Citation Analysis]
12 Guo L, Xu N, Qiu D, Yang X, Zhao S, Zhao H. Comprehensive analysis of m6A-modified circRNAs in peritoneal metastasis of high grade serious carcinoma of ovary. Front Oncol 2022;12:988578. [DOI: 10.3389/fonc.2022.988578] [Reference Citation Analysis]
13 Ghasemii K, Darroudi M, Rahimmanesh I, Ghomi M, Hassanpour M, Sharifi E, Yousefiasl S, Ahmadi S, Zarrabi A, Borzacchiello A, Rabiee M, Paiva-santos AC, Rabiee N. Advances in aptamer-based drug delivery vehicles for cancer therapy. Biomaterials Advances 2022;140:213077. [DOI: 10.1016/j.bioadv.2022.213077] [Reference Citation Analysis]
14 Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomed Pharmacother 2022;154:113609. [PMID: 36037786 DOI: 10.1016/j.biopha.2022.113609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Guo Y, Feng L. N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway. Arch Biochem Biophys 2022;:109381. [PMID: 36027936 DOI: 10.1016/j.abb.2022.109381] [Reference Citation Analysis]
16 Duan L, Xia Y, Li C, Lan N, Hou X. Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer. Front Genet 2022;13:906900. [DOI: 10.3389/fgene.2022.906900] [Reference Citation Analysis]
17 Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. J Exp Clin Cancer Res 2022;41:214. [PMID: 35773731 DOI: 10.1186/s13046-022-02406-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
18 Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol 2022;11:39. [PMID: 35761419 DOI: 10.1186/s40164-022-00292-z] [Reference Citation Analysis]
19 Luo X, Gao Q, Zhou T, Tang R, Zhao Y, Zhang Q, Wang N, Ye H, Chen X, Chen S, Tang W, Zhao D. FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway. Front Oncol 2022;12:900836. [PMID: 35720005 DOI: 10.3389/fonc.2022.900836] [Reference Citation Analysis]
20 Ashrafizadeh M, Zarrabi A, Karimi‐maleh H, Taheriazam A, Mirzaei S, Hashemi M, Hushmandi K, Makvandi P, Nazarzadeh Zare E, Sharifi E, Goel A, Wang L, Ren J, Nuri Ertas Y, Kumar AP, Wang Y, Rabiee N, Sethi G, Ma Z. (Nano)platforms in bladder cancer therapy: Challenges and opportunities. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol 2022;15:50. [PMID: 35524266 DOI: 10.1186/s13045-022-01276-6] [Reference Citation Analysis]
22 Gao X, Cai J. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer. Front Genet 2022;13:865204. [DOI: 10.3389/fgene.2022.865204] [Reference Citation Analysis]
23 Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Non-coding RNAs and macrophage interaction in tumor progression. Crit Rev Oncol Hematol 2022;:103680. [PMID: 35405273 DOI: 10.1016/j.critrevonc.2022.103680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
24 Iranmanesh H, Entezari M, Rejali L, Nazemalhosseini-mojarad E, Maghsoudloo M, Aghdaei HA, Zali MR, Hushmandi K, Rabiee N, Makvandi P, Ashrafizadeh M, Hashemi M. The Association of Clinicopathological Characterizations of Colorectal Cancer with Membrane-Bound Mucins genes and LncRNAs. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153883] [Reference Citation Analysis]